Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata6
|
ENSMUSG00000005836.8 | GATA binding protein 6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_11317630_11317906 | Gata6 | 258721 | 0.015447 | 0.69 | 4.3e-09 | Click! |
chr18_11330243_11330685 | Gata6 | 271417 | 0.014096 | -0.69 | 7.4e-09 | Click! |
chr18_11317253_11317420 | Gata6 | 258289 | 0.015496 | 0.63 | 2.4e-07 | Click! |
chr18_11239938_11240114 | Gata6 | 180979 | 0.029536 | -0.60 | 1.3e-06 | Click! |
chr18_11317026_11317208 | Gata6 | 258070 | 0.015521 | 0.51 | 6.9e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_83898401_83898573 | 43.25 |
Mesd |
mesoderm development LRP chaperone |
3434 |
0.14 |
chr6_116350044_116350568 | 25.31 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
79 |
0.95 |
chr14_121355790_121356113 | 25.16 |
Stk24 |
serine/threonine kinase 24 |
3917 |
0.25 |
chr6_33055731_33056078 | 22.44 |
Chchd3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
4313 |
0.2 |
chr1_134426409_134426588 | 22.27 |
Platr1 |
pluripotency associated transcript 1 |
9130 |
0.1 |
chr5_67280465_67280714 | 22.01 |
Gm42670 |
predicted gene 42670 |
19327 |
0.15 |
chr13_112024736_112025023 | 21.88 |
Gm15323 |
predicted gene 15323 |
19377 |
0.18 |
chr11_69585627_69586063 | 20.28 |
Trp53 |
transformation related protein 53 |
2850 |
0.09 |
chr9_48362196_48362510 | 20.15 |
Nxpe4 |
neurexophilin and PC-esterase domain family, member 4 |
312 |
0.89 |
chr13_101611824_101612000 | 19.99 |
Gm29341 |
predicted gene 29341 |
5679 |
0.22 |
chr3_85725215_85725405 | 19.30 |
Fam160a1 |
family with sequence similarity 160, member A1 |
16079 |
0.22 |
chr13_111656903_111657234 | 17.62 |
Mier3 |
MIER family member 3 |
23911 |
0.13 |
chr6_5186341_5186502 | 17.21 |
Pon1 |
paraoxonase 1 |
7342 |
0.2 |
chr6_56920853_56921008 | 16.77 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
2794 |
0.17 |
chr7_103825988_103826174 | 16.22 |
Hbb-bs |
hemoglobin, beta adult s chain |
1644 |
0.14 |
chr16_58669361_58669681 | 16.14 |
Cpox |
coproporphyrinogen oxidase |
771 |
0.54 |
chr10_43791761_43792071 | 15.97 |
Gm9034 |
predicted pseudogene 9034 |
29315 |
0.12 |
chr19_60872283_60872608 | 15.88 |
Prdx3 |
peroxiredoxin 3 |
2111 |
0.23 |
chr11_58353112_58353501 | 15.72 |
Sh3bp5l |
SH3 binding domain protein 5 like |
7994 |
0.1 |
chr3_98855197_98855511 | 15.47 |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
4440 |
0.12 |
chr18_68274920_68275099 | 15.22 |
Mir7219 |
microRNA 7219 |
14036 |
0.15 |
chr11_11735229_11735403 | 15.06 |
Gm12000 |
predicted gene 12000 |
38877 |
0.13 |
chr17_42884465_42884760 | 14.74 |
Cd2ap |
CD2-associated protein |
7947 |
0.29 |
chr13_24551558_24551922 | 14.38 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
30449 |
0.15 |
chr1_184928501_184928704 | 14.21 |
Gm38251 |
predicted gene, 38251 |
5466 |
0.21 |
chr5_146250723_146251020 | 14.13 |
Gm15739 |
predicted gene 15739 |
2320 |
0.2 |
chr6_83032753_83034325 | 14.10 |
Dok1 |
docking protein 1 |
68 |
0.86 |
chr7_25273837_25274017 | 14.09 |
Cic |
capicua transcriptional repressor |
4495 |
0.1 |
chr11_63353114_63353308 | 14.05 |
Gm12286 |
predicted gene 12286 |
39900 |
0.17 |
chr16_91441869_91442151 | 13.85 |
Gm46562 |
predicted gene, 46562 |
16411 |
0.09 |
chr2_27982205_27982376 | 13.83 |
Col5a1 |
collagen, type V, alpha 1 |
35151 |
0.16 |
chr11_86664070_86664249 | 13.83 |
Vmp1 |
vacuole membrane protein 1 |
586 |
0.71 |
chr6_127322417_127322756 | 13.23 |
Gm42458 |
predicted gene 42458 |
3271 |
0.16 |
chr8_83215030_83215277 | 13.19 |
Tbc1d9 |
TBC1 domain family, member 9 |
44106 |
0.11 |
chr10_61123250_61123407 | 13.09 |
Gm44308 |
predicted gene, 44308 |
1907 |
0.27 |
chr3_98856982_98857468 | 13.08 |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
2569 |
0.16 |
chr6_97405399_97405733 | 12.87 |
Frmd4b |
FERM domain containing 4B |
8830 |
0.24 |
chr9_32162830_32163115 | 12.86 |
Gm47536 |
predicted gene, 47536 |
12196 |
0.19 |
chr11_58917742_58917901 | 12.74 |
Btnl10 |
butyrophilin-like 10 |
87 |
0.91 |
chr11_29814877_29815214 | 12.67 |
Eml6 |
echinoderm microtubule associated protein like 6 |
6617 |
0.16 |
chr11_109557350_109557676 | 12.61 |
Arsg |
arylsulfatase G |
13759 |
0.16 |
chr2_104098671_104098841 | 12.58 |
Cd59a |
CD59a antigen |
2916 |
0.17 |
chr11_61075746_61075902 | 12.57 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
10020 |
0.17 |
chr4_41129904_41130072 | 12.55 |
Gm12402 |
predicted gene 12402 |
2856 |
0.14 |
chr17_50425186_50425351 | 12.45 |
Plcl2 |
phospholipase C-like 2 |
84135 |
0.08 |
chr10_61412962_61413255 | 12.44 |
Nodal |
nodal |
4864 |
0.13 |
chr1_59183133_59183356 | 12.42 |
Mpp4 |
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
19855 |
0.12 |
chr5_134919074_134919381 | 12.42 |
4933439J24Rik |
RIKEN cDNA 4933439J24 gene |
561 |
0.47 |
chr11_98911514_98911727 | 12.40 |
Cdc6 |
cell division cycle 6 |
3469 |
0.14 |
chr13_32993547_32993707 | 12.31 |
Gm47662 |
predicted gene, 47662 |
3435 |
0.16 |
chr6_5291230_5291963 | 12.30 |
Pon2 |
paraoxonase 2 |
2528 |
0.26 |
chr7_110914639_110914941 | 12.25 |
Mrvi1 |
MRV integration site 1 |
8913 |
0.17 |
chr8_80493820_80494107 | 12.24 |
Gypa |
glycophorin A |
182 |
0.96 |
chr16_36890595_36890747 | 12.16 |
Gm49600 |
predicted gene, 49600 |
3723 |
0.12 |
chr1_181323221_181323527 | 12.15 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
29254 |
0.13 |
chr5_99669969_99670445 | 12.03 |
Gm16226 |
predicted gene 16226 |
12203 |
0.14 |
chr3_19650569_19650855 | 11.96 |
Trim55 |
tripartite motif-containing 55 |
6204 |
0.16 |
chr16_97606087_97606240 | 11.92 |
Tmprss2 |
transmembrane protease, serine 2 |
4806 |
0.24 |
chr7_51991063_51991344 | 11.88 |
Svip |
small VCP/p97-interacting protein |
14495 |
0.16 |
chr18_74729732_74729894 | 11.86 |
Myo5b |
myosin VB |
3952 |
0.23 |
chr2_84052178_84052355 | 11.86 |
Gm13692 |
predicted gene 13692 |
17653 |
0.15 |
chr2_77672640_77672815 | 11.82 |
Zfp385b |
zinc finger protein 385B |
30545 |
0.23 |
chrX_9256889_9257156 | 11.77 |
Gm14862 |
predicted gene 14862 |
123 |
0.95 |
chr7_120861739_120862019 | 11.67 |
Eef2k |
eukaryotic elongation factor-2 kinase |
10690 |
0.13 |
chr6_122394205_122394556 | 11.62 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
3001 |
0.17 |
chr11_85107327_85107485 | 11.62 |
Rpl13-ps1 |
ribosomal protein L13, pseudogene 1 |
4387 |
0.16 |
chr11_96926664_96926823 | 11.59 |
Prr15l |
proline rich 15-like |
1361 |
0.23 |
chr1_86479174_86479713 | 11.48 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr5_73311488_73311911 | 11.45 |
Gm42732 |
predicted gene 42732 |
335 |
0.78 |
chr9_64806290_64806632 | 11.44 |
Dennd4a |
DENN/MADD domain containing 4A |
4879 |
0.23 |
chr14_48538228_48538390 | 11.42 |
4930572G02Rik |
RIKEN cDNA 4930572G02 gene |
13 |
0.96 |
chr10_86990643_86991042 | 11.39 |
Gm16269 |
predicted gene 16269 |
9455 |
0.15 |
chr5_123193467_123193813 | 11.38 |
Gm43409 |
predicted gene 43409 |
2052 |
0.17 |
chr13_83382718_83382891 | 11.38 |
Mef2c |
myocyte enhancer factor 2C |
121230 |
0.06 |
chr8_114879117_114879445 | 11.38 |
Wwox |
WW domain-containing oxidoreductase |
167114 |
0.03 |
chr12_111517954_111518283 | 11.37 |
Gm40578 |
predicted gene, 40578 |
17278 |
0.1 |
chr8_105448296_105448456 | 11.34 |
Lrrc36 |
leucine rich repeat containing 36 |
4537 |
0.12 |
chr15_98827590_98827953 | 11.33 |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
1643 |
0.18 |
chr9_120112501_120112831 | 11.33 |
Slc25a38 |
solute carrier family 25, member 38 |
2184 |
0.13 |
chr18_24158931_24159082 | 11.32 |
Ino80c |
INO80 complex subunit C |
37053 |
0.15 |
chr15_83592885_83593046 | 11.31 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
2192 |
0.23 |
chr12_91757977_91758292 | 11.31 |
Ston2 |
stonin 2 |
12050 |
0.17 |
chr13_111940877_111941182 | 11.29 |
Gm15322 |
predicted gene 15322 |
50437 |
0.1 |
chr1_170622997_170623376 | 11.29 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr11_87726236_87726559 | 11.26 |
Rnf43 |
ring finger protein 43 |
1029 |
0.34 |
chr17_28832918_28833228 | 11.25 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
4991 |
0.11 |
chr2_34762357_34762541 | 11.24 |
Gapvd1 |
GTPase activating protein and VPS9 domains 1 |
7217 |
0.14 |
chr1_193001027_193001405 | 11.24 |
Syt14 |
synaptotagmin XIV |
34428 |
0.13 |
chr7_48992020_48992183 | 11.22 |
Nav2 |
neuron navigator 2 |
33004 |
0.14 |
chr1_90246675_90247087 | 11.22 |
Gm28721 |
predicted gene 28721 |
13239 |
0.16 |
chr7_115846115_115846283 | 11.21 |
Sox6 |
SRY (sex determining region Y)-box 6 |
48 |
0.99 |
chr4_53432052_53432206 | 11.21 |
Slc44a1 |
solute carrier family 44, member 1 |
8284 |
0.22 |
chr12_83579151_83579469 | 11.21 |
Zfyve1 |
zinc finger, FYVE domain containing 1 |
16377 |
0.14 |
chr2_71874194_71874386 | 11.17 |
Pdk1 |
pyruvate dehydrogenase kinase, isoenzyme 1 |
547 |
0.77 |
chr11_11733313_11733627 | 11.17 |
Gm12000 |
predicted gene 12000 |
37031 |
0.13 |
chr5_30287283_30287470 | 11.14 |
Drc1 |
dynein regulatory complex subunit 1 |
5988 |
0.17 |
chr11_120980134_120980295 | 11.11 |
Csnk1d |
casein kinase 1, delta |
8589 |
0.1 |
chr15_67114820_67115136 | 11.09 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
986 |
0.65 |
chr7_106652317_106652613 | 11.08 |
Olfr693 |
olfactory receptor 693 |
26020 |
0.11 |
chr7_103811571_103811767 | 11.08 |
Hbb-bt |
hemoglobin, beta adult t chain |
2327 |
0.1 |
chr12_80776376_80776562 | 11.01 |
Gm47941 |
predicted gene, 47941 |
13874 |
0.11 |
chr7_143004700_143005061 | 10.99 |
Tspan32 |
tetraspanin 32 |
166 |
0.92 |
chr2_73093042_73093445 | 10.97 |
Gm13665 |
predicted gene 13665 |
23505 |
0.16 |
chr2_152122973_152123233 | 10.96 |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
17579 |
0.13 |
chr11_53483659_53483860 | 10.95 |
Sowaha |
sosondowah ankyrin repeat domain family member A |
3485 |
0.1 |
chr8_86759318_86759496 | 10.87 |
Siah1a |
siah E3 ubiquitin protein ligase 1A |
13473 |
0.17 |
chr10_127291987_127292158 | 10.86 |
Ddit3 |
DNA-damage inducible transcript 3 |
1243 |
0.18 |
chr9_44580129_44580422 | 10.83 |
Gm47230 |
predicted gene, 47230 |
648 |
0.47 |
chr18_54436351_54436509 | 10.79 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
14135 |
0.23 |
chr18_70563066_70563368 | 10.76 |
Mbd2 |
methyl-CpG binding domain protein 2 |
4972 |
0.2 |
chr7_103854782_103854952 | 10.74 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
1651 |
0.14 |
chr10_86025984_86026319 | 10.74 |
A230060F14Rik |
RIKEN cDNA A230060F14 gene |
3822 |
0.13 |
chr8_107437145_107437413 | 10.71 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
863 |
0.47 |
chr13_14033395_14033670 | 10.66 |
Tbce |
tubulin-specific chaperone E |
6047 |
0.13 |
chr15_44459924_44460237 | 10.66 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
2527 |
0.25 |
chr11_31843822_31844223 | 10.65 |
Gm12107 |
predicted gene 12107 |
11362 |
0.18 |
chr7_109636438_109636727 | 10.65 |
Denn2b |
DENN domain containing 2B |
19435 |
0.15 |
chr6_120174417_120174862 | 10.64 |
Ninj2 |
ninjurin 2 |
19184 |
0.18 |
chr9_71146317_71146483 | 10.63 |
Aqp9 |
aquaporin 9 |
16233 |
0.17 |
chr9_120115481_120115991 | 10.61 |
Slc25a38 |
solute carrier family 25, member 38 |
747 |
0.41 |
chr6_103700350_103700641 | 10.60 |
Chl1 |
cell adhesion molecule L1-like |
2745 |
0.34 |
chr17_49438920_49439085 | 10.60 |
Mocs1 |
molybdenum cofactor synthesis 1 |
5806 |
0.23 |
chr12_32104526_32104851 | 10.59 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
19014 |
0.16 |
chr4_123286770_123287029 | 10.59 |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
3804 |
0.11 |
chr12_116277072_116277240 | 10.58 |
Gm11027 |
predicted gene 11027 |
1770 |
0.23 |
chr3_133624021_133624348 | 10.57 |
Gm37228 |
predicted gene, 37228 |
10574 |
0.17 |
chr5_36620484_36620644 | 10.56 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
691 |
0.54 |
chr3_94666026_94666207 | 10.52 |
BC021767 |
cDNA sequence BC021767 |
15 |
0.95 |
chr10_11323594_11323775 | 10.47 |
Gm48666 |
predicted gene, 48666 |
6731 |
0.15 |
chr1_59894146_59894414 | 10.46 |
Gm37977 |
predicted gene, 37977 |
6591 |
0.15 |
chr2_103957767_103958059 | 10.46 |
Lmo2 |
LIM domain only 2 |
73 |
0.96 |
chr12_40888538_40889137 | 10.45 |
Gm7239 |
predicted gene 7239 |
4223 |
0.18 |
chr15_5659100_5659292 | 10.45 |
Gm18715 |
predicted gene, 18715 |
54838 |
0.14 |
chr7_141132187_141132543 | 10.42 |
Ptdss2 |
phosphatidylserine synthase 2 |
73 |
0.93 |
chr7_35556972_35557137 | 10.41 |
Nudt19 |
nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
750 |
0.49 |
chr3_102167860_102168094 | 10.39 |
Vangl1 |
VANGL planar cell polarity 1 |
1004 |
0.46 |
chr13_95688563_95688884 | 10.38 |
Gm48745 |
predicted gene, 48745 |
3578 |
0.17 |
chr7_127586221_127586455 | 10.37 |
Ccdc189 |
coiled-coil domain containing 189 |
2 |
0.93 |
chr5_146679205_146679645 | 10.36 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
27197 |
0.15 |
chr14_76882933_76883168 | 10.36 |
Gm48969 |
predicted gene, 48969 |
21479 |
0.19 |
chr6_135166144_135166455 | 10.33 |
Hebp1 |
heme binding protein 1 |
1836 |
0.21 |
chr15_5139978_5140135 | 10.33 |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
3805 |
0.13 |
chr18_63203873_63204037 | 10.31 |
Gm50171 |
predicted gene, 50171 |
35483 |
0.17 |
chr10_75706088_75706403 | 10.29 |
Cabin1 |
calcineurin binding protein 1 |
5870 |
0.14 |
chr5_143655651_143655837 | 10.29 |
Cyth3 |
cytohesin 3 |
4503 |
0.22 |
chr15_100420062_100420229 | 10.25 |
Gm5475 |
predicted gene 5475 |
2002 |
0.19 |
chr18_54437459_54437788 | 10.25 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
15328 |
0.22 |
chr16_32487182_32487452 | 10.23 |
Slc51a |
solute carrier family 51, alpha subunit |
386 |
0.79 |
chrX_136135584_136135889 | 10.23 |
Bex4 |
brain expressed X-linked 4 |
3260 |
0.16 |
chr11_11522162_11522332 | 10.19 |
Spata48 |
spermatogenesis associated 48 |
32981 |
0.14 |
chr6_100624120_100624319 | 10.19 |
Gm44108 |
predicted gene, 44108 |
2721 |
0.23 |
chr7_110774760_110775022 | 10.18 |
Ampd3 |
adenosine monophosphate deaminase 3 |
647 |
0.63 |
chr19_37141710_37142020 | 10.16 |
Gm22714 |
predicted gene, 22714 |
7297 |
0.16 |
chr14_20599676_20599956 | 10.15 |
Usp54 |
ubiquitin specific peptidase 54 |
5514 |
0.13 |
chr7_90046913_90047179 | 10.14 |
Gm44861 |
predicted gene 44861 |
4349 |
0.15 |
chr11_85298057_85298378 | 10.14 |
Ppm1d |
protein phosphatase 1D magnesium-dependent, delta isoform |
13027 |
0.18 |
chr13_24159698_24160005 | 10.13 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
4642 |
0.22 |
chr1_165356506_165356657 | 10.12 |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
4583 |
0.18 |
chr3_14890958_14891109 | 10.11 |
Car2 |
carbonic anhydrase 2 |
4394 |
0.22 |
chr7_38105330_38105806 | 10.10 |
Ccne1 |
cyclin E1 |
1340 |
0.4 |
chr10_30749396_30749716 | 10.09 |
Gm48335 |
predicted gene, 48335 |
5594 |
0.16 |
chr7_4739300_4740219 | 10.08 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr2_152814243_152814528 | 10.07 |
Bcl2l1 |
BCL2-like 1 |
14150 |
0.12 |
chr2_35419345_35419505 | 10.07 |
Ggta1 |
glycoprotein galactosyltransferase alpha 1, 3 |
3902 |
0.16 |
chr2_125665964_125666238 | 10.06 |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
6994 |
0.2 |
chr2_28616890_28617255 | 10.06 |
Gfi1b |
growth factor independent 1B |
1667 |
0.23 |
chr11_89017566_89017738 | 10.05 |
Trim25 |
tripartite motif-containing 25 |
18276 |
0.1 |
chr6_90623557_90623713 | 10.05 |
Slc41a3 |
solute carrier family 41, member 3 |
4488 |
0.16 |
chr4_150152597_150152838 | 10.04 |
Slc2a7 |
solute carrier family 2 (facilitated glucose transporter), member 7 |
3745 |
0.15 |
chr3_52985507_52985880 | 10.03 |
Cog6 |
component of oligomeric golgi complex 6 |
8992 |
0.16 |
chr4_32173214_32173372 | 10.03 |
Gm11928 |
predicted gene 11928 |
23507 |
0.18 |
chr7_29339251_29339558 | 10.03 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
341 |
0.83 |
chr16_77028015_77028313 | 10.01 |
Usp25 |
ubiquitin specific peptidase 25 |
14377 |
0.21 |
chr13_61805425_61805580 | 9.96 |
Gm7240 |
predicted gene 7240 |
1236 |
0.28 |
chr1_129990849_129991148 | 9.96 |
Gm37278 |
predicted gene, 37278 |
47836 |
0.15 |
chr3_145590718_145590904 | 9.94 |
Znhit6 |
zinc finger, HIT type 6 |
5057 |
0.23 |
chr5_106705212_106705518 | 9.89 |
Zfp644 |
zinc finger protein 644 |
8078 |
0.14 |
chr15_66827533_66827688 | 9.88 |
Sla |
src-like adaptor |
4036 |
0.23 |
chr2_163358720_163358895 | 9.87 |
Tox2 |
TOX high mobility group box family member 2 |
38429 |
0.11 |
chr6_41704227_41704508 | 9.86 |
Kel |
Kell blood group |
28 |
0.96 |
chr16_33764464_33764783 | 9.84 |
Heg1 |
heart development protein with EGF-like domains 1 |
8100 |
0.18 |
chr8_83423048_83423368 | 9.83 |
Scoc |
short coiled-coil protein |
14619 |
0.13 |
chr4_8685673_8685832 | 9.82 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
4654 |
0.27 |
chr13_90890229_90890480 | 9.81 |
Atp6ap1l |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
8470 |
0.2 |
chr10_25299127_25299474 | 9.80 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
136 |
0.89 |
chr5_120599719_120599896 | 9.80 |
Rita1 |
RBPJ interacting and tubulin associated 1 |
5910 |
0.09 |
chr11_95793003_95793275 | 9.79 |
Phospho1 |
phosphatase, orphan 1 |
31360 |
0.09 |
chr19_5268996_5269230 | 9.79 |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
3594 |
0.1 |
chr14_31045396_31045562 | 9.75 |
Gm49094 |
predicted gene, 49094 |
2359 |
0.15 |
chr13_24160091_24160265 | 9.75 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
4969 |
0.21 |
chr16_32508765_32508924 | 9.74 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
9233 |
0.13 |
chr3_51388963_51389125 | 9.73 |
Mgarp |
mitochondria localized glutamic acid rich protein |
7444 |
0.1 |
chr12_69758521_69758986 | 9.73 |
Mir681 |
microRNA 681 |
5191 |
0.14 |
chr2_90870358_90870623 | 9.72 |
Mtch2 |
mitochondrial carrier 2 |
7031 |
0.11 |
chr2_180684164_180684334 | 9.72 |
Dido1 |
death inducer-obliterator 1 |
8294 |
0.12 |
chr13_24419481_24419859 | 9.71 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2446 |
0.22 |
chr1_75136821_75137108 | 9.69 |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
842 |
0.37 |
chr6_66053332_66053505 | 9.68 |
Gm5876 |
predicted gene 5876 |
57781 |
0.1 |
chr14_27349855_27350152 | 9.67 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
11386 |
0.2 |
chr2_45041006_45041210 | 9.66 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
13133 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 22.8 | GO:0032264 | IMP salvage(GO:0032264) |
5.1 | 15.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
4.0 | 20.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.9 | 3.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
3.2 | 12.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
2.9 | 11.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.8 | 8.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.7 | 10.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.7 | 2.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
2.7 | 10.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.7 | 8.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.6 | 10.5 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
2.5 | 7.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.4 | 7.2 | GO:0002432 | granuloma formation(GO:0002432) |
2.2 | 6.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.1 | 6.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.1 | 10.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
2.1 | 6.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
2.1 | 6.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.0 | 12.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.0 | 2.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
2.0 | 5.9 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.8 | 9.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.8 | 9.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.8 | 5.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.8 | 5.3 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.7 | 5.0 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.6 | 3.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
1.6 | 9.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.6 | 4.9 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.6 | 9.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.6 | 4.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.5 | 10.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.5 | 7.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.5 | 4.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.5 | 4.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.5 | 4.4 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
1.4 | 5.8 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.4 | 1.4 | GO:0097503 | sialylation(GO:0097503) |
1.3 | 5.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.3 | 11.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.3 | 3.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.3 | 3.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.2 | 3.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.2 | 4.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.2 | 3.6 | GO:0032898 | neurotrophin production(GO:0032898) |
1.2 | 6.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.2 | 1.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.2 | 3.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.2 | 8.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
1.2 | 2.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.2 | 3.5 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.1 | 9.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.1 | 3.4 | GO:1903416 | response to glycoside(GO:1903416) |
1.1 | 2.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.1 | 3.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 3.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.1 | 4.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.1 | 2.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.1 | 5.5 | GO:0009642 | response to light intensity(GO:0009642) |
1.1 | 1.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.1 | 4.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.1 | 10.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.1 | 4.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.0 | 4.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.0 | 5.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.0 | 3.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.0 | 9.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.0 | 25.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.0 | 4.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.0 | 2.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.0 | 6.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.0 | 3.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.0 | 3.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.0 | 7.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.0 | 1.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.0 | 5.8 | GO:0015871 | choline transport(GO:0015871) |
1.0 | 2.9 | GO:0032439 | endosome localization(GO:0032439) |
1.0 | 6.7 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
1.0 | 3.8 | GO:0050904 | diapedesis(GO:0050904) |
1.0 | 1.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.9 | 1.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.9 | 2.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 2.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.9 | 5.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 4.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.9 | 4.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.9 | 12.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.9 | 6.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.9 | 16.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.9 | 4.5 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.9 | 2.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 3.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.9 | 4.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 3.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.9 | 2.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 0.9 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.9 | 1.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.9 | 5.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.9 | 1.7 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.9 | 1.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 0.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.8 | 2.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 2.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 0.8 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.8 | 1.7 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.8 | 2.5 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.8 | 1.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.8 | 9.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.8 | 2.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.8 | 3.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.8 | 2.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.8 | 0.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 0.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.8 | 4.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 3.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.8 | 4.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.8 | 1.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.8 | 3.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.8 | 17.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.8 | 2.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 3.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.8 | 4.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 4.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.8 | 3.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 1.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.8 | 2.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.7 | 1.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.7 | 3.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.7 | 2.2 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.7 | 2.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 0.7 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.7 | 2.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 2.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.7 | 3.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.7 | 2.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 2.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.7 | 4.3 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.7 | 3.5 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.7 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 9.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.7 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.7 | 2.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.7 | 2.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.7 | 4.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 0.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.7 | 2.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 3.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.7 | 2.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.7 | 2.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 4.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.7 | 10.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.7 | 2.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 4.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.7 | 0.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.7 | 3.3 | GO:0070627 | ferrous iron import(GO:0070627) |
0.7 | 2.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.7 | 2.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.7 | 2.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 1.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 3.9 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.6 | 3.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.6 | 6.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.6 | 5.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.6 | 7.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.6 | 2.5 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 6.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.6 | 11.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 3.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 6.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 2.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.6 | 5.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.6 | 3.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 3.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.6 | 1.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.6 | 1.9 | GO:0001555 | oocyte growth(GO:0001555) |
0.6 | 3.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.6 | 1.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.6 | 2.5 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.6 | 1.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.6 | 5.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.6 | 4.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.6 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.6 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.6 | 1.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.6 | 6.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 1.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.6 | 1.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.6 | 1.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 1.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.6 | 2.9 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 1.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 1.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.6 | 5.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 1.7 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.6 | 1.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 5.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 2.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.6 | 4.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 5.7 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 2.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.6 | 2.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 2.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.6 | 1.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 5.6 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.6 | 1.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.6 | 1.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.6 | 0.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 2.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.6 | 2.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.6 | 1.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.6 | 2.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 4.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 0.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 0.5 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.5 | 4.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.5 | 2.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 6.0 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 14.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 1.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.5 | 1.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.5 | 3.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 1.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.5 | 1.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 3.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 3.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 1.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 1.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.5 | 6.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.5 | 1.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.5 | 1.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 1.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.5 | 1.6 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.5 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 1.5 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.5 | 1.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.5 | 1.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.5 | 1.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.5 | 0.5 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.5 | 1.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.5 | 0.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 1.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 2.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.5 | 1.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 1.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 2.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.5 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 1.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 1.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 9.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.5 | 1.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 1.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.5 | 1.4 | GO:0061727 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.5 | 1.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 1.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 2.8 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.5 | 1.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 2.3 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.5 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 1.4 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.5 | 1.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 1.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 1.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 0.5 | GO:0090114 | cargo loading into COPII-coated vesicle(GO:0090110) COPII-coated vesicle budding(GO:0090114) |
0.5 | 2.3 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.5 | 0.5 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 0.5 | GO:0060214 | endocardium formation(GO:0060214) |
0.5 | 3.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 0.9 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.5 | 3.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 1.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 1.3 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.4 | 2.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 2.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 0.9 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 1.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 0.4 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.4 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 1.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.4 | 2.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.4 | 7.5 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.4 | 2.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 3.1 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 1.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 1.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 3.9 | GO:0044241 | lipid digestion(GO:0044241) |
0.4 | 3.5 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.4 | 4.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.4 | 0.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 1.3 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 1.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 1.3 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.4 | 0.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 1.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 1.7 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.4 | 2.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 1.3 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.4 | 0.4 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 0.8 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.4 | 3.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 2.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 7.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 5.0 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.4 | 2.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 1.7 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 1.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 0.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.6 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.4 | 1.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 1.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 2.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 0.8 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.4 | 2.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 2.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 3.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 3.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 1.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 0.8 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 0.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 0.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 1.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 0.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.4 | 0.8 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.4 | 0.8 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 4.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.4 | 1.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 2.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.4 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 1.2 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 2.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 0.4 | GO:0070989 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.4 | 0.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.4 | 1.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.4 | 1.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.2 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.4 | 0.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.4 | 0.4 | GO:0036394 | amylase secretion(GO:0036394) |
0.4 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 0.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 2.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.4 | 0.8 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.4 | 0.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.4 | 3.4 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 1.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 0.8 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.4 | 0.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 0.4 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 1.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 3.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 1.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 3.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 0.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 0.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.4 | 1.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.4 | 3.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 0.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 3.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 1.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 3.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 1.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 0.4 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.4 | 2.6 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.4 | 1.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 2.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 6.2 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.4 | 2.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 2.2 | GO:0033572 | transferrin transport(GO:0033572) |
0.4 | 3.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 5.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 0.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 1.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.4 | 1.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 1.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 1.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 2.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.4 | 2.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 7.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 7.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 1.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 6.6 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.3 | 1.4 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 2.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 2.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 1.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 1.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 1.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 0.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.3 | 0.7 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.3 | 3.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.3 | 4.8 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.3 | 2.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 0.7 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.3 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 2.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.3 | 1.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 1.0 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 0.7 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.3 | 1.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 0.7 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 8.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.7 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.3 | 1.3 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.3 | 1.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 2.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 5.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 1.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 5.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 2.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 1.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.9 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 1.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 1.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.6 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 8.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 2.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 3.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 10.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.3 | 9.3 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.3 | 2.6 | GO:0050892 | intestinal absorption(GO:0050892) |
0.3 | 1.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.3 | 1.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.6 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 1.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 0.9 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 2.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.6 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 4.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.9 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) positive regulation of interleukin-13 production(GO:0032736) |
0.3 | 0.6 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.3 | 5.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 1.2 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 2.1 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.3 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.3 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 0.3 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.3 | 3.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 2.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.3 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 0.6 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 6.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.3 | 0.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.9 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 1.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 1.5 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 4.4 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.3 | 0.3 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.3 | 1.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 1.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.3 | 0.9 | GO:0046959 | habituation(GO:0046959) |
0.3 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 2.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 2.3 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.9 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 6.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 0.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 2.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.9 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.3 | 2.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 2.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 1.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 2.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 3.7 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 1.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 1.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.3 | 0.6 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.3 | 0.3 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.3 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.3 | 4.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.3 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 0.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 2.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.3 | 1.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 1.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 1.4 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 0.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 0.3 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 1.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 1.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 2.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 2.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 3.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 1.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 0.5 | GO:1901300 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 2.6 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 0.5 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.3 | 3.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.5 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 2.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 1.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 2.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 1.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 2.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 1.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 2.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 2.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 1.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 4.1 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.3 | 2.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 1.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 0.3 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.3 | 1.8 | GO:0042640 | anagen(GO:0042640) |
0.3 | 0.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 0.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 0.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 4.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 2.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 1.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.2 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 2.5 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.2 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 3.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 2.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 1.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 1.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 2.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 4.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.7 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.2 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 1.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 0.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 9.5 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.2 | 6.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 2.1 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.2 | 1.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.5 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.9 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 1.8 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 0.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 1.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 2.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.7 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 1.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.9 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 0.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 0.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 6.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 1.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.2 | 0.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 1.7 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 1.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 1.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 1.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 1.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 5.5 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.2 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.2 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) positive regulation of response to cytokine stimulus(GO:0060760) |
0.2 | 1.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 1.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.2 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 0.6 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.4 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 1.6 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.2 | 1.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 2.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.6 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.2 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 1.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 2.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 1.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.8 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 2.2 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 3.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.2 | 1.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 3.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 2.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 1.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 1.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 1.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.6 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 1.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.2 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 1.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 1.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 2.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 1.1 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.2 | 0.8 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.4 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 7.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 1.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.6 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 7.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 0.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 2.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 0.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 2.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.2 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.5 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 2.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 1.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.9 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.2 | 0.4 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.2 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 1.6 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.5 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.2 | 0.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 0.2 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.2 | 1.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.3 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.2 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 11.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 1.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.7 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 3.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 0.2 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 0.2 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.2 | 0.2 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.2 | 0.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.5 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.2 | 4.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.2 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 2.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.3 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.2 | 2.5 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.2 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 6.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 1.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 0.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 4.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 0.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 2.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.2 | 0.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 1.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.2 | 1.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 1.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 0.2 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.2 | 0.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 0.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.5 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 4.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 2.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.6 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.3 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 4.8 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.1 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 1.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 1.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.6 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 1.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 1.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 3.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.6 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.1 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 4.3 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.0 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 3.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 1.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 3.1 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.7 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.1 | 0.1 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 1.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.7 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 2.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 1.2 | GO:0032438 | melanosome organization(GO:0032438) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 2.1 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.1 | 1.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.5 | GO:0014063 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 2.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.9 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 1.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.1 | 0.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.5 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 0.2 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.9 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 0.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 1.8 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 1.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.1 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.1 | 0.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.9 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.3 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.1 | 0.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.5 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 5.6 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.1 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.1 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 1.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.8 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 2.1 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.5 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.5 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 1.7 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 1.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 1.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.3 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.5 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 1.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 2.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.5 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.7 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0090220 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 3.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 1.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 1.8 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.2 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.1 | GO:0006639 | acylglycerol metabolic process(GO:0006639) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 1.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.4 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.9 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 2.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 1.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.9 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.2 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.8 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 2.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.1 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.1 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.1 | 0.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.2 | GO:0032109 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 7.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0003192 | mitral valve formation(GO:0003192) |
0.1 | 1.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 2.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 1.7 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0002423 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.2 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.3 | GO:0051177 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 1.3 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.8 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.4 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 1.7 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 1.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.0 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.1 | 1.6 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.5 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) reverse cholesterol transport(GO:0043691) |
0.1 | 0.3 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 1.4 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 1.4 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.1 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.1 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.1 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.1 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.1 | GO:0036166 | phenotypic switching(GO:0036166) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.4 | GO:0051053 | negative regulation of DNA metabolic process(GO:0051053) |
0.1 | 0.2 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 1.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.3 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 1.4 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.1 | 0.1 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.1 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 0.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.8 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.0 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 4.3 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.0 | 0.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.3 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0043038 | amino acid activation(GO:0043038) |
0.0 | 0.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.9 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.0 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 1.0 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.4 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 0.2 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.0 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 1.3 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.5 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.0 | 1.2 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.3 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 0.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.0 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.0 | 0.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.0 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.1 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.0 | 0.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.0 | 0.1 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.1 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.5 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 1.1 | GO:0035264 | multicellular organism growth(GO:0035264) |
0.0 | 0.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0046794 | transport of virus(GO:0046794) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.0 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.0 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 1.9 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.0 | 0.0 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.1 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.0 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.0 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.0 | 0.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.4 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.0 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 19.9 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 3.4 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.0 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.0 | GO:0002832 | negative regulation of response to biotic stimulus(GO:0002832) |
0.0 | 0.1 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.0 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.0 | GO:0072666 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.0 | GO:0097531 | mast cell migration(GO:0097531) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.0 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.0 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.0 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.4 | 9.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.6 | 4.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.6 | 10.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.5 | 5.8 | GO:0070545 | PeBoW complex(GO:0070545) |
1.4 | 4.2 | GO:0000811 | GINS complex(GO:0000811) |
1.4 | 2.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.3 | 6.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.2 | 4.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.2 | 3.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.1 | 5.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.1 | 4.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.1 | 8.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.1 | 8.5 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 16.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.0 | 3.0 | GO:1990423 | RZZ complex(GO:1990423) |
1.0 | 4.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 2.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.9 | 0.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.9 | 2.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.9 | 3.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.8 | 2.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 2.5 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 2.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 5.4 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 1.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 3.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 8.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 2.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 3.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.7 | 5.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 2.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.7 | 3.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.7 | 2.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 3.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 9.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 1.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 3.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.6 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 1.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.6 | 4.9 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.6 | 0.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.6 | 9.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.6 | 1.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 3.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.6 | 3.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 1.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 5.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 2.3 | GO:0098536 | deuterosome(GO:0098536) |
0.6 | 3.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 3.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 6.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.5 | 5.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.5 | 3.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.5 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 5.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 1.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 1.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.5 | 3.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.5 | 1.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 7.8 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 3.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 2.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 9.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.5 | 1.9 | GO:0044299 | C-fiber(GO:0044299) |
0.5 | 4.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 4.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 2.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 1.9 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 1.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 20.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 12.9 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 1.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 11.9 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 0.9 | GO:0042627 | chylomicron(GO:0042627) |
0.4 | 2.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 4.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.7 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 1.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.4 | 2.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 3.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.4 | 0.8 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 1.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 1.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 0.4 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 9.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 1.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 6.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 4.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 2.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.4 | 11.4 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 4.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 1.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 20.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 1.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 1.5 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 3.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 5.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.4 | 1.8 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 5.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 1.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 3.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 3.9 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 1.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 8.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 1.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 2.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 16.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 8.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 2.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 3.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 1.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 2.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 1.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 5.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 3.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 3.3 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 3.9 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 3.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 1.2 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 2.0 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.3 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 5.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 3.0 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 0.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 2.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 4.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 2.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 1.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 15.3 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 4.8 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 4.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 12.2 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 6.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.0 | GO:0043230 | extracellular organelle(GO:0043230) |
0.2 | 3.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 7.1 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 3.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 1.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 5.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 27.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 3.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 2.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.2 | 7.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 2.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 73.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 12.1 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 1.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 8.4 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 2.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 7.3 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 3.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 11.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 6.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 4.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 2.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 1.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 6.1 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 8.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 1.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 7.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.8 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 3.1 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.8 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 4.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.7 | GO:0005901 | caveola(GO:0005901) |
0.2 | 3.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 5.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.8 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 2.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 13.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 1.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 9.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 19.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 3.3 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 3.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 9.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.5 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 4.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 4.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 3.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 2.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 30.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 5.7 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 2.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 1.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 2.5 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 1.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 18.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.3 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 1.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 3.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0036452 | ESCRT III complex(GO:0000815) ESCRT complex(GO:0036452) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 30.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 2.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.2 | GO:0043205 | fibril(GO:0043205) |
0.1 | 9.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 8.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 2.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 86.5 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.2 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 20.0 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.6 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 10.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 101.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 1.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 1.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.0 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.4 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 1.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 5.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 15.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 1.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.0 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
5.0 | 14.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.0 | 8.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.9 | 11.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.8 | 11.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.7 | 8.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.7 | 8.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.5 | 7.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.2 | 6.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.1 | 6.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.9 | 5.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.8 | 5.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.8 | 8.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.7 | 5.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.7 | 5.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.6 | 4.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.6 | 11.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.6 | 4.8 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.6 | 4.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.6 | 15.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.4 | 4.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.4 | 18.4 | GO:0016208 | AMP binding(GO:0016208) |
1.4 | 4.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.4 | 4.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.3 | 5.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.3 | 3.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.3 | 6.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.3 | 9.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.2 | 3.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.2 | 3.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.1 | 8.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.1 | 3.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.1 | 7.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.1 | 3.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.1 | 3.2 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 4.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.0 | 4.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 5.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.0 | 4.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.0 | 8.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.0 | 5.1 | GO:0043559 | insulin binding(GO:0043559) |
1.0 | 3.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.0 | 5.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.0 | 3.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.0 | 3.0 | GO:0043199 | sulfate binding(GO:0043199) |
1.0 | 4.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 2.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.9 | 3.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.9 | 2.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.9 | 2.8 | GO:0019961 | interferon binding(GO:0019961) |
0.9 | 2.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.9 | 2.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.9 | 2.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 3.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.9 | 2.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.9 | 3.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.9 | 7.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 4.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.8 | 8.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 2.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.8 | 2.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 3.3 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 1.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 8.6 | GO:0015250 | water channel activity(GO:0015250) |
0.8 | 2.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 3.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 10.5 | GO:0016918 | retinal binding(GO:0016918) |
0.7 | 4.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 2.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.7 | 2.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 2.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 2.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.7 | 3.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 2.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 2.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.7 | 2.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 3.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.7 | 2.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.7 | 2.1 | GO:2001070 | starch binding(GO:2001070) |
0.7 | 2.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 2.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.7 | 2.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 2.7 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.7 | 8.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.7 | 8.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 0.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.6 | 3.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 5.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 1.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 0.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.6 | 1.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 3.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.6 | 2.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 1.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 5.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 3.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 2.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 9.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.6 | 4.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.6 | 4.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 2.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 4.0 | GO:0018632 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 2.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 1.7 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.6 | 1.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 8.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 2.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.6 | 2.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 1.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.6 | 5.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 12.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 2.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 2.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 16.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.5 | 3.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 1.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 1.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 2.1 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 3.2 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.5 | 1.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 3.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 3.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 3.2 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 2.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.5 | 2.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 4.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 7.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 7.2 | GO:0016594 | glycine binding(GO:0016594) |
0.5 | 4.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.5 | 1.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 1.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 5.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 5.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 5.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 1.5 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 1.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 4.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 2.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 8.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 7.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 3.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 1.5 | GO:0051379 | epinephrine binding(GO:0051379) |
0.5 | 4.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.5 | 3.8 | GO:0032942 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 4.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 1.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 14.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 3.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 31.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.5 | 0.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 5.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 3.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 2.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.4 | 1.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 8.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 2.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 3.0 | GO:0060229 | lipase activator activity(GO:0060229) |
0.4 | 6.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 0.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 1.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 7.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 1.2 | GO:0035276 | ethanol binding(GO:0035276) |
0.4 | 0.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.7 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 2.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 2.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.4 | 1.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 1.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 2.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 1.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 8.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 2.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 9.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.4 | 1.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 3.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.4 | 12.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.4 | 1.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 2.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 0.7 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.4 | 4.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 3.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 5.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 3.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 1.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 0.4 | GO:0004937 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 4.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 1.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.3 | 5.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 3.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 3.7 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 6.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 1.0 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 1.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.3 | GO:0035671 | enone reductase activity(GO:0035671) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 4.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 1.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.0 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 3.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 4.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 6.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 2.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 3.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 3.8 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 0.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 0.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 4.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 2.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 12.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 2.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 4.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 2.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 0.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 4.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 1.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 3.4 | GO:0019176 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.3 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 0.8 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 4.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 3.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 0.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 1.6 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 5.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 2.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 0.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 7.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 2.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 1.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 2.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 2.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 12.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 15.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 2.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 1.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 4.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 17.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 1.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 2.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 1.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 2.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 1.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 1.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 4.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 2.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 4.0 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 10.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 3.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 3.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 1.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 2.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 4.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 7.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 3.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.3 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 8.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 1.6 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 2.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 3.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 4.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 4.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 6.1 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 1.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 3.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 2.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 2.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 6.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 2.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.3 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 8.0 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 6.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 3.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.0 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 1.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 0.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 18.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 2.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 1.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 2.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 4.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 6.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 3.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 17.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 2.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 8.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 7.8 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 5.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.2 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 2.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.5 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 9.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.0 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 2.0 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 9.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 0.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 2.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 3.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 4.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.9 | GO:0052687 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 0.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 2.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 9.4 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 3.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 3.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.6 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 5.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 23.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 7.0 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 2.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.8 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 1.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 2.6 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 24.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.7 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.4 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.2 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 6.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 2.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 21.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 6.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 3.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 1.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 16.7 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 1.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 10.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 2.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.1 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.5 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.7 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.9 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 3.4 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 8.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 7.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.5 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 1.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 2.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 2.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 11.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.8 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 12.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.1 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.6 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.1 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.1 | 0.4 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 5.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 5.1 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 2.1 | GO:0020037 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.3 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 5.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.2 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 4.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 25.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 8.8 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.6 | 8.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 15.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 3.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 10.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 13.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 23.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 8.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 11.8 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 4.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 14.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 17.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 5.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 26.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 11.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 0.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 1.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 2.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 8.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 6.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 11.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 3.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 4.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 7.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 8.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 1.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 13.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 5.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 5.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 2.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 5.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 5.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 11.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 6.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 7.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 1.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 3.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 4.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 8.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 3.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 1.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 6.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 6.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 2.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 4.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 1.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 16.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 9.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 3.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 4.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 4.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 3.2 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 2.5 | PID ATM PATHWAY | ATM pathway |
0.2 | 5.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 5.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 2.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 2.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 6.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 6.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 26.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.9 | 26.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.6 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.2 | 20.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.0 | 7.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.9 | 14.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.9 | 9.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 8.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.8 | 8.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 4.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 7.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 6.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 15.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.7 | 6.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.7 | 6.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 9.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 6.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 8.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 5.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.6 | 6.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 7.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 10.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.5 | 3.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 5.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 2.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 4.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 11.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 7.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 13.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 2.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.5 | 33.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 3.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 7.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 3.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 11.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 4.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 9.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 3.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 2.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 2.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 2.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 6.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 12.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 1.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 2.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 4.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 5.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 5.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 3.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 5.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 0.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 1.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 5.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 6.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 13.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 2.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 3.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 4.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 3.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 19.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 0.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 9.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 1.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 1.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.3 | 3.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 6.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 2.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 1.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.3 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 1.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 1.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 2.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 6.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 5.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 12.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 7.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 8.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 4.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 4.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 6.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 4.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 4.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 5.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 3.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 3.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 2.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 3.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 0.6 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.2 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 18.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 8.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 4.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 3.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 4.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 8.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 4.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 2.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 1.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 5.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 3.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 4.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 3.9 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 1.5 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 1.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 15.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 5.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 4.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 6.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 3.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 2.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.8 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.4 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.2 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 3.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 5.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 2.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |